This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stroke, Volume 56, Issue Suppl_1 , Page A139-A139, February 1, 2025. We divided this population into 3 groups: (a) those with a diagnosis of CAA, (b) those with other cerebrovasculardisease without CAA, and (c) those without CAA or other cerebrovasculardisease. and prevalent cerebrovasculardisease (HR, 1.4;
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. He had a documented history of transient‐ischemic attack and was noted to have undergone progressive cognitive decline.
Stroke, Volume 56, Issue Suppl_1 , Page AHUP2-AHUP2, February 1, 2025. Introduction:Cerebrovascular disease, a leading cause of death in the U.S., Although mortality trends by sex, race, and ethnicity are well-documented, geographic variations across the U.S. remain underexplored. to -1.80, p < 0.001).
Stroke, Volume 56, Issue Suppl_1 , Page A109-A109, February 1, 2025. Introduction:Cerebrovascular disease, a leading cause of death in the U.S., Although mortality trends by sex, race, and ethnicity are well-documented, geographic variations across the U.S. remain underexplored. to -1.80, p < 0.001).
Stroke, Volume 56, Issue Suppl_1 , Page AWP313-AWP313, February 1, 2025. Introduction:In mid- to high-latitude regions, cerebrovasculardiseases (CBVD) are known to peak during the winter. Seasonality and climate factors can be considered predisposing risk factors for cerebrovasculardisease.
They increase the risk of hypertension, coronary artery disease, coronary vasospasm, arrhythmias, cardiomyopathy, cardiac arrest, and stroke. Introduction:Cocaine and methamphetamine, stimulants with potent central nervous system effects, are known to be cardiotoxic. decline in overall CVD mortality rates (Table).
SOB or Hypoxemia (obviously) Vasovagal (Neurocardiogenic syncope or Reflex Syncope) is the most common cause of cardiac syncope, even in patients with cardiac disease: In this entity, there is BOTH a bradycardic and/or a vasodepressor response. to 1.45) for fatal or nonfatal stroke. g/dL Hypotension (obviously!) to 3.80).
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content